Projected Earnings Date: 2024-08-19    (Delayed quote data   2025-01-06)
Last
 1.33
Change
 ⇓ -0.05   (-3.99%)
Volume
  507,592
Open
 1.44
High
 1.45
Low
 1.30
8EMA (Daily)
 1.20
40EMA (Daily)
 1.06
50EMA (Daily)
 1.07
STO (Daily)
 88.349
MACD Hist (Daily)
 0.104
8EMA (Weekly)
 1.155
40EMA (Weekly)
 1.47
50EMA (Weekly)
 1.62
STO (Weekly)
 58.808
MACD Hist (Weekly)
 0.136
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com